QIAGEN N.V. (QGEN) Total liabilities 2016–2025
QIAGEN N.V. (QGEN) total liabilities at each fiscal year-end, per SEC filings.
$2.5BFY2025 · since FY2016: $1.7B → $2.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5B | +17.9% |
| FY2024 | $2.1B | -8.0% |
| FY2023 | $2.3B | -18.2% |
| FY2022 | $2.8B | -7.5% |
| FY2021 | $3.1B | -0.7% |
| FY2020 | $3.1B | +13.8% |
| FY2019 | $2.7B | -13.3% |
| FY2018 | $3.1B | +24.7% |
| FY2017 | $2.5B | +46.8% |
| FY2016 | $1.7B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More QGEN financial trends
QGEN RevenueQGEN Net incomeQGEN Net marginQGEN Gross profitQGEN Gross marginQGEN Operating incomeQGEN Operating marginQGEN Operating cash flowQGEN Free cash flowQGEN Capital expendituresQGEN Return on equityQGEN Stock buybacksQGEN Dividends paidQGEN Total assetsQGEN Shareholders’ equityQGEN overview →